ARYE RUBINSTEIN, MD
Osteopathic Medicine at Blondell Ave, Bronx, NY

License number
New York 123252
Category
Osteopathic Medicine
Type
Allergy & Immunology
Address
Address 2
1525 Blondell Ave, Bronx, NY 10461
25 Astor Pl, Chestnut Ridge, NY 10952
Phone
(718) 405-8530
(718) 405-8532 (Fax)

Personal information

See more information about ARYE RUBINSTEIN at radaris.com
Name
Address
Phone
Arye Rubinstein
25 Astor Pl, Monsey, NY 10952
Arye Rubinstein
Spring Valley, NY
(845) 354-4302
Arye Rubinstein
11 Ralph Pl, Staten Island, NY 10304
Arye Rubinstein
229 97Th St, New York, NY 10025
Arye Rubinstein
24 Astor Pl, Monsey, NY 10952

Organization information

See more information about ARYE RUBINSTEIN at bizstanding.com

Arye Rubenstein

1180 Morris Park Ave, Bronx, NY 10461

Industry:
Allergist, Pediatric Allergist, Pediatrician
Doing business as:
Arye Rubinstein MD
Phone:
(718) 863-8465 (Phone)
Arye Rubinstein

Professional information

See more information about ARYE RUBINSTEIN at trustoria.com
Arye Rubinstein Photo 1
Dr. Arye Rubinstein, Bronx NY - MD (Doctor of Medicine)

Dr. Arye Rubinstein, Bronx NY - MD (Doctor of Medicine)

Specialties:
Pediatrics, Allergy & Immunology
Address:
Family Immunology Center
1525 Blondell Ave SUITE 101, Bronx 10461
(718) 405-8530 (Phone)
Advanced Allergy & Asthma Care
11 Ralph Pl SUITE 305, Staten Island 10304
(718) 273-9111 (Phone)
Certifications:
Allergy & Immunology, 1977, Pediatrics, 1976
Awards:
Healthgrades Honor Roll
Languages:
English, German
Hospitals:
Family Immunology Center
1525 Blondell Ave SUITE 101, Bronx 10461
Advanced Allergy & Asthma Care
11 Ralph Pl SUITE 305, Staten Island 10304
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Montefiore Medical Center - Wakefield
600 East 233Rd St, Bronx 10466
Education:
Medical School
University of Bern / Medical Faculty
University Tel Aviv
Graduated: 1964
Graduated: 1967
Harvard Med School
Graduated: 1973
University Bern
Graduated: 1969


Arye Dr Rubinstein Photo 2
Arye DR Rubinstein, Bronx NY

Arye DR Rubinstein, Bronx NY

Specialties:
Allergy & Immunology, Allergy, Pediatrics, Pediatric Allergy & Immunology
Work:
Montefiore Medical Center
1180 Morris Park Ave, Bronx, NY 10461 Children's Hospital at Montefiore Medical Center
3415 Bainbridge Ave, Bronx, NY 10467 Montefiore Medical Center
111 E 210Th St, Bronx, NY 10467 Staten Island Allergy Office Professional Corp.
11 Ralph Pl, Staten Island, NY 10304 Yeshiva University
1525 Blondell Ave, Bronx, NY 10461 MMC -Family Care Center
3444 Kossuth Ave, Bronx, NY 10467
Education:
Universitat Bern (1962)


Arye Rubinstein Photo 3
Use Of Butylurea As A Contraceptive Agent

Use Of Butylurea As A Contraceptive Agent

US Patent:
5229423, Jul 20, 1993
Filed:
Mar 6, 1992
Appl. No.:
7/847193
Inventors:
Arye Rubinstein - Monsey NY
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 3117
US Classification:
514588
Abstract:
This invention relates to the use of butylurea as a contraceptive agent. Butylurea may be used either alone or with a pharmaceutically acceptable carrier, and may be used in conjunction with conventional contraceptive means to abrogate sperm motility.


Arye Rubinstein Photo 4
Use Of Alkylureas For Treating Acne

Use Of Alkylureas For Treating Acne

US Patent:
2005027, Dec 8, 2005
Filed:
Feb 2, 2005
Appl. No.:
11/049377
Inventors:
Arye Rubinstein - Wesley Hills NY, US
International Classification:
A61K031/17
US Classification:
514588000
Abstract:
Methods of treating acne are provided. The methods involve applying to the acne an alkyl urea in a pharmaceutically acceptable carrier. The use of an alkyl urea in the manufacture of a medicament for the treatment of acne is also provided. Compositions of alkyl ureas in a pharmaceutically acceptable carrier are additionally provided.


Arye Rubinstein Photo 5
Use Of Alkylureas For Treating Acne

Use Of Alkylureas For Treating Acne

US Patent:
2011012, May 26, 2011
Filed:
Nov 5, 2010
Appl. No.:
12/927102
Inventors:
Arye Rubinstein - Wesley Hills NY, US
International Classification:
A61K 31/17, C07C 275/06, A61K 9/127, A61P 17/10
US Classification:
424450, 514588, 564 58
Abstract:
Methods of treating acne are provided. The methods involve applying to the acne an alkyl urea in a pharmaceutically acceptable carrier. The use of an alkyl urea in the manufacture of a medicament for the treatment of acne is also provided. Compositions of alkyl ureas in a pharmaceutically acceptable carrier are additionally provided.


Arye Rubinstein Photo 6
Use Of Butylurea, Nonoxynol-9 And Benzalkonium Chloride As Anti-Bacterial, Anti-Viral Contraceptive Agents

Use Of Butylurea, Nonoxynol-9 And Benzalkonium Chloride As Anti-Bacterial, Anti-Viral Contraceptive Agents

US Patent:
5387611, Feb 7, 1995
Filed:
Jun 3, 1993
Appl. No.:
8/071723
Inventors:
Arye Rubinstein - Monsey NY
Assignee:
Albert Einstein College of Medicine of Yeshiva University, a Division of
Yeshiva University - Bronx NY
International Classification:
A61K 3117, A61K 3114, A61K 31075
US Classification:
514588
Abstract:
This invention relates to methods of abrogating sperm motility utilizing the anti-bacterial, anti-viral agents butylurea, Nonoxynol-9 and benzalkonium chloride. This invention is further directed to anti-bacterial, anti-viral, non-irritating contraceptive compositions, and to methods of enhancing contraceptive capabilities of conventional contraceptive means as well as to enhanced conventional contraceptive means.


Arye Rubinstein Photo 7
Bloodbag And Method Of Making Same

Bloodbag And Method Of Making Same

US Patent:
5300059, Apr 5, 1994
Filed:
Nov 19, 1991
Appl. No.:
7/794381
Inventors:
Arye Rubinstein - Monsey NY
Albert Goldstein - Trenton Falls NJ
Howard I. Podell - New Rochelle NY
Assignee:
Hydro Slip Technologies Inc. - Howell NJ
Albert Einstein College of Medicine - New York NY
International Classification:
A61J 100
US Classification:
604408
Abstract:
The interior surface of a container, such as a bloodbag, is primed and subsequently coated with a time-releasable viricide against HIV absorbed in a hydrogel polymer. The viricides of this invention are derivatives of urea, and upon release into the blood, have no adverse effects on the red blood cell functions of the blood.